Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
O-GlcNAc Transferase p110 subunit Antibody (HL1641) - Azide and BSA Free, Novus Biologicals™

Rabbit Monoclonal Antibody
Supplier: Novus Biologicals NBP325586
Description
O-GlcNAc Transferase p110 subunit Monoclonal antibody specifically detects O-GlcNAc Transferase p110 subunit in Human, Mouse, Rat, Drosophila samples. It is validated for Western Blot, Immunohistochemistry, Immunocytochemistry/ Immunofluorescence, Immunohistochemistry (Paraffin)Specifications
O-GlcNAc Transferase p110 subunit | |
Monoclonal | |
Unconjugated | |
PBS | |
Rabbit | |
Protein A purified | |
RUO | |
Primary | |
Human, Mouse, Rat, Drosophila | |
Purified |
Western Blot, Immunohistochemistry, Immunocytochemistry, Immunohistochemistry (Paraffin) | |
HL1641 | |
Western Blot 1:500-1:3000, Immunohistochemistry, Immunocytochemistry/ Immunofluorescence, Immunohistochemistry-Paraffin | |
EC 2.4.1, EC 2.4.1.255, FLJ23071, HRNT1, MGC22921, O-GLCNAC, O-GlcNAc transferase p110 subunit, O-GlcNAc transferase subunit p110, O-linked N-acetylglucosamine (GlcNAc) transferase(UDP-N-acetylglucosamine:polypeptide-N-acetylglucosaminyl transferase), O-linked N-acetylglucosamine transferase 110 kDa subunit, UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDasubunit, uridinediphospho-N-acetylglucosamine:polypeptide beta-N-acetylglucosaminyltransferase | |
Recombinant protein encompassing a sequence within the center region of human O-GlcNAc Transferase p110 subunit. The exact sequence is proprietary. | |
100 μL | |
Amino Acids Drugs and other small molecules, Cellular Markers, Golgi Apparatus Markers, Stem Cell Markers | |
8473 | |
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction